Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment

Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has gi...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaral, Teresa Maria Santos, Macedo, Daniela, Fernandes, Isabel, Costa, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316959/
https://www.ncbi.nlm.nih.gov/pubmed/22530130
http://dx.doi.org/10.1155/2012/327253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316959/
https://www.ncbi.nlm.nih.gov/pubmed/22530130
http://dx.doi.org/10.1155/2012/327253

Ejemplares similares